TROGARZO is a drug for the treatment of human immunodeficiency virus 1 (HIV-1) infection in adults who:
- have received several anti-HIV-1 regimens in the past, and
- have HIV-1 virus that is not responding to many antiretroviral medicines, and
- who are failing their current antiretroviral therapy
HIV-1 is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).
TROGARZO is used in combination with other antiretroviral medications. TROGARZO is is given by a health care professional once every two weeks directly into the bloodstream through a needle in the vein. This is known as an intravenous, or IV infusion. It takes 15-30 minutes to receive TROGARZO infusion.A new DRUG TRIALS SNAPSHOT is now available